ProShares Ultra Nasdaq BiotechnologyBIB:NMQ:USD

2.91 / 4.65%
42.50 - 106.10+1.22
Latest price in USDToday's change52-week range3-yr sharpe ratio
Data delayed at least 15 minutes, as of Oct 06 2015 14:43 BST.


The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in securities and derivatives that ProShare Advisors believes, in combination, should have similar daily return characteristics as two times (2x) the daily return of the index. The index is a modified capitalization weighted index that includes securities of NASDAQ listed companies that are classified as either biotechnology or pharmaceutical according to the Industry Classification Benchmark ("ICB") which also meet other eligibility criteria determined by NASDAQ. The fund is non-diversified.


Fund typeOpen Ended Investment Company
Investment style (stocks)
Market Cap: Large
Investment Style: Growth
Morningstar categoryTrading-Leveraged Equity
Launch date06/04/2010
Price currencyUSD
DomicileUnited States
Manager & start date
Michael Neches
Charles Lowery


Total net assets
649.90m USDAs of Sep 30 2015
Market cap405.42m USD
Shares outstanding6.80m
Average volume (10-day)2.19m
Net expense ratio0.95%
Last dividend--
Div yield0.00%
Div ex-date--
Div pay-date--
Available for saleUnited States


Asset type

US stock
Non-US stock
US bond
Non-US bond

Top 5 sectors

Cash & Equivalents

Top 5 Regions

Regional weighting data is unavailable.
Sector and region weightings are calculated using only long position holdings of the portfolio.Sector & regional holdings

Top 5 holdings

Company1 year
Nasdaq Biotechnology Index Swap Credit Suisse International--67.07%
Ishares Biotech (Ibb) Swap Morgan Stanley & Co. International Plc--27.88%
Ishares Biotech (Ibb) Swap Deutsche Bank Ag--8.89%
Nasdaq Biotechnology Index Swap Ubs Ag--7.64%
Nasdaq Biotechnology Index Swap Bank Of America, Na--5.76%
Data delayed at least 15 minutes, as of Jun 30 2015. Top 10 holdings
Intra-day ETF pricing data provided by
© Thomson Reuters Click for restrictions.

The performance data shown in tables and graphs on this page is calculated in USD of the fund / index / average (as applicable), on a Bid To Bid / Nav to Nav basis, with gross dividends re-invested on ex-dividend date. Past performance is not necessarily a guide to future performance; unit prices may fall as well as rise.

All managed funds data located on is subject to the FT Terms & Conditions . All content on is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

All data shown on this page, unless noted otherwise is Data Source and Copyright: Morningstar, Inc. 2015
All Rights reserved

© 2015 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.

The Morningstar Equity Style Box is a unique graphical tool showing a fund’s true investment style and market capitalisation.

The Morningstar Fixed Income Style Box is a unique graphical tool showing a fund's true credit quality and duration.

Pricing for ETFs is the latest price and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.